ArticleScientific reports2026
Joint genetic control of isoflavones and soyasaponins revealed by mGWAS, genomic prediction, and SHAP-guided allele stacking.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Isoflavones and soyasaponins are two classes of health-promoting specialized metabolites in soybean, and improving them simultaneously is a key breeding goal. Emerging evidence indicates that these two metabolite classes can act synergistically in vivo and in vitro, making their simultaneous enhancement an increasingly important breeding objective. However, despite extensive studies on each pathway independently, the genetic basis underlying joint variation of isoflavones and soyasaponins remains poorly understood. Here, we profiled 17 metabolites (12 isoflavones and 5 soyasaponins) across 376 accessions of the Korean soybean core collection using UPLC. We characterized metabolite distributions, correlations, and presence–absence patterns, and performed multi-metabolite Genome-Wide Association Study (GWAS), identifying 70 high-confidence loci. These included previously reported major loci as well as eight novel loci for isoflavones and thirteen for soyasaponins. Five genomic regions showed shared linkage disequilibrium (LD) structure between the two pathways, and we identified candidate genes for high-confidence loci. We next compared FT-IR–based phenomic prediction with GWAS-informed genomic prediction, finding that genomic prediction consistently outperformed phenomic prediction and achieved moderate to high accuracy, indicating strong genetic determinism. Finally, we applied an XGBoost– SHapley Additive exPlanations (SHAP) framework to estimate the extent to which favorable alleles could be combined in silico. Single-trait allele stacking pointed to CMJ_115, CMJ_068, and CMJ_236 as the best-performing accessions for Acetyl-daidzin, Malonyl-daidzin, and Soyasaponin-ab, respectively. Multi-trait optimization produced a virtual genotype most similar to CMJ_317, suggesting this accession as a practical parent for jointly improving both metabolite classes. Overall, our findings provide a population-scale map of diversity, genetic factors, and achievable breeding gains for functional soybean improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.